A cost-effectiveness analysis of Maraviroc in treatment-experienced HIV patients in Scotland

Hiv Patients ◽

Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: a cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF v2 (protocols.io.qnpdvdn)

protocols.io ◽

10.17504/protocols.io.qnpdvdn ◽

2018 ◽

Author(s):

Stefano Orlando ◽

Isotta triulzi ◽

Fausto Ciccacci ◽

Ilaria Palla ◽

Leonardo Palombi ◽

...

Keyword(s):

Cost Effectiveness ◽

Delayed Diagnosis ◽

Diagnosis And Treatment ◽

Smear Microscopy ◽

Hiv Patients ◽

Symptom Screening ◽

Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain

Enfermedades Infecciosas y Microbiología Clínica ◽

10.1016/j.eimc.2009.09.010 ◽

2010 ◽

Vol 28 (9) ◽

pp. 590-595 ◽

Cited By ~ 19

Author(s):

Diana Nieves Calatrava ◽

Óscar de la Calle-Martín ◽

José A. Iribarren-Loyarte ◽

Antonio Rivero-Román ◽

Laura García-Bujalance ◽

...

Keyword(s):

Cost Effectiveness ◽

Hiv Patients ◽

Cost-Effectiveness Analysis of Dolutegravir for HIV Patients in Slovenia

Value in Health ◽

10.1016/j.jval.2014.08.2495 ◽

2014 ◽

Vol 17 (7) ◽

pp. A673 ◽

Cited By ~ 2

Author(s):

R. Hren ◽

R. Refoios Camejo

Keyword(s):

Cost Effectiveness ◽

Hiv Patients ◽

Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients

Value in Health ◽

10.1016/j.jval.2014.08.2550 ◽

2014 ◽

Vol 17 (7) ◽

pp. A683

Author(s):

L. Oddershede ◽

S. Walker ◽

N. Paton ◽

W. Stöhr ◽

D. Dunn ◽

...

Keyword(s):

Cost Effectiveness ◽

Protease Inhibitor ◽

Triple Therapy ◽

Hiv Patients ◽

Effectiveness Analysis ◽

Protease Inhibitor Monotherapy ◽

Term Management

Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF

PLoS ONE ◽

10.1371/journal.pone.0200523 ◽

2018 ◽

Vol 13 (7) ◽

pp. e0200523 ◽

Cited By ~ 8

Author(s):

S. Orlando ◽

I. Triulzi ◽

F. Ciccacci ◽

I. Palla ◽

L. Palombi ◽

...

Keyword(s):

Cost Effectiveness ◽

Delayed Diagnosis ◽

Diagnosis And Treatment ◽

Smear Microscopy ◽

Hiv Patients ◽

Symptom Screening ◽

A Cost-Effectiveness Analysis Of Two Patient-Level Reminder Interventions To Increase Adherence Among Hiv Patients In Mexico

Value in Health ◽

10.1016/j.jval.2013.03.421 ◽

2013 ◽

Vol 16 (3) ◽

pp. A90-A91

Author(s):

A. Azamar ◽

S. Bautista ◽

J. Sierra ◽

G. Sanchez

Keyword(s):

Cost Effectiveness ◽

Hiv Patients ◽

Patient Level ◽

Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients

Journal of the International AIDS Society ◽

10.7448/ias.17.4.19498 ◽

2014 ◽

Vol 17 ◽

pp. 19498 ◽

Cited By ~ 5

Author(s):

Lars Oddershede ◽

Simon Walker ◽

Nicholas Paton ◽

Wolfgang Stöhr ◽

David Dunn ◽

...

Keyword(s):

Cost Effectiveness ◽

Protease Inhibitor ◽

Triple Therapy ◽

Hiv Patients ◽

Effectiveness Analysis ◽

Protease Inhibitor Monotherapy ◽

Term Management

PID1: COST-EFFECTIVENESS ANALYSIS OF RECOMBINANT HUMAN ERYTHROPOIETIN VERSUS TRANSFUSION IN HIV PATIENTS TREATED WITH ZIDOVUDINE

Value in Health ◽

10.1016/s1098-3015(11)70962-7 ◽

1999 ◽

Vol 2 (3) ◽

pp. 182

Author(s):

M Juzba ◽

J Hay

Keyword(s):

Cost Effectiveness ◽

Recombinant Human Erythropoietin ◽

Hiv Patients ◽

Human Erythropoietin ◽

Erratum to “Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain”

Enfermedades Infecciosas y Microbiología Clínica ◽

10.1016/j.eimc.2011.10.010 ◽

2012 ◽

Vol 30 (6) ◽

pp. 356

Author(s):

Diana Nieves Calatrava ◽

Óscar de la Calle-Martín ◽

José A. Iribarren-Loyarte ◽

Antonio Rivero-Román ◽

Laura García-Bujalance ◽

...

Keyword(s):

Cost Effectiveness ◽

Hiv Patients ◽

Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: a cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF v1 (protocols.io.qnndvde)

protocols.io ◽

10.17504/protocols.io.qnndvde ◽

2018 ◽

Author(s):

Stefano Orlando ◽

Isotta triulzi ◽

Fausto Ciccacci ◽

Ilaria Palla ◽

Leonardo Palombi ◽

...

Keyword(s):

Cost Effectiveness ◽

Delayed Diagnosis ◽

Diagnosis And Treatment ◽

Smear Microscopy ◽

Hiv Patients ◽

Symptom Screening ◽